MedTech News
.................... by Andrew Celentano
Ultrasound paired with vibrating nanoparticles softens tumor tissue, improving drug delivery
Cancer is one of the leading causes of death in the U.S., second only to heart disease. But a new cancer treatment method from CU Boulder researchers uses sound waves to soften tumors and could be a potent tool against the disease.
A urine-based biological aging clock: Machine learning and microRNA offer accurate prediction
Craif Inc. in Nagoya, Japan, working with Nagoya University’s Institute of Innovation for Future Society, has developed a urine-based biological aging clock. In validation of the method, predicted ages came within 4.4 years of chronological age on average.
Prostate cancer cells use unique metabolic pathway to thrive in bone tissue
A University of Kentucky Markey Cancer Center study reveals how prostate cancer cells adapt their metabolism to thrive in bone tissue, offering a potential new treatment target for patients with advanced disease.
Cancer’s hidden ‘safety switch’: Silencing TAK1 gene could boost immunotherapy performance
Australian researchers have discovered that the TAK1 gene helps cancer cells survive attack from the immune system, revealing a mechanism that may limit the effectiveness of immunotherapy treatments.
Scientists 3D print a living, beating human heart
Researchers at Tel Aviv University achieved a medical milestone once thought impossible: creating a living, beating human heart using a patient’s own fat cells.
Zoll launches 5th-gen wearable cardioverter defibrillator
Zoll announced today that it launched its next-generation LifeVest wearable cardioverter defibrillator (WCD) in the U.S.
New Raman imaging system detects subtle tumor signals
Researchers have developed a new compact Raman imaging system that is sensitive enough to differentiate between tumor and normal tissue. The system offers a promising route to earlier cancer detection and to making molecular imaging more practical outside the lab.
Hidden ‘switches’ in DNA reveal new insights into Alzheimer’s disease
A tiny percentage of our DNA—around 2%—contains 20,000-odd genes. The remaining 98%—long known as the non-coding genome, or so-called ‘junk’ DNA—includes many of the “switches” that control when and how strongly genes are expressed.